OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production within Chinese hamster ovary (CHO) cells is a paramount challenge to the biopharmaceutical industry. A variety of strategies can be employed enhance antibody titer, such as process parameter optimization, media optimization, and adoption of perfusion technologies. Fine-tuning growth parameters p